| Dabigatran (high dose) |
| Strengths |
Weaknesses |
| stroke and systemic embolism than warfarin |
extracranial bleeding than warfarin in the elderly (age > 75 years) |
| ischaemic stroke than warfarin |
GI bleeding than warfarin |
| |
tolerability compared to warfarin (dyspepsia) |
| |
Twice daily dosing |
